These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35052697)

  • 21. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs.
    Mohamed MF; Hammac GK; Guptill L; Seleem MN
    PLoS One; 2014; 9(12):e116259. PubMed ID: 25551573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Characterization and Broad-Spectrum Bactericidal Effects of Ammonium Methyl and Ammonium Ethyl Styrene-Based Nanoparticles.
    Alfei S; Caviglia D; Piatti G; Zuccari G; Schito AM
    Nanomaterials (Basel); 2022 Aug; 12(16):. PubMed ID: 36014607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Luminescent CdSe Quantum Dot-Functionalized Antimicrobial Peptides Nanoparticles on Antibacterial Activity and Molecular Mechanism.
    Li W; Song P; Xin Y; Kuang Z; Liu Q; Ge F; Zhu L; Zhang X; Tao Y; Zhang W
    Int J Nanomedicine; 2021; 16():1849-1867. PubMed ID: 33707943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulation of propolis extracted with methylal in the chitosan nanoparticles and its antibacterial and cell cytotoxicity studies.
    Vaseghi A; Parchin RA; Chamanie KR; Herb M; Maleki H; Sadeghizadeh M
    BMC Complement Med Ther; 2024 Apr; 24(1):165. PubMed ID: 38641781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.
    Piras AM; Maisetta G; Sandreschi S; Gazzarri M; Bartoli C; Grassi L; Esin S; Chiellini F; Batoni G
    Front Microbiol; 2015; 6():372. PubMed ID: 25972852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus.
    Scolari IR; Páez PL; Musri MM; Petiti JP; Torres A; Granero GE
    Drug Deliv Transl Res; 2020 Oct; 10(5):1403-1417. PubMed ID: 32363536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of bacteriophages for staphylococcal infections and selected methods for in vitro susceptibility testing of staphylococci.
    Dvořáčková M; Růžička F; Dvořáková Heroldová M; Vacek L; Bezděková D; Benešík M; Petráš P; Pantůček R
    Epidemiol Mikrobiol Imunol; 2020; 69(1):10-18. PubMed ID: 32326711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercaptophenylboronic Acid-Activated Gold Nanoparticles as Nanoantibiotics against Multidrug-Resistant Bacteria.
    Wang L; Yang J; Yang X; Hou Q; Liu S; Zheng W; Long Y; Jiang X
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51148-51159. PubMed ID: 33155812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
    Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
    Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of
    Ugur AR; Dagi HT; Ozturk B; Tekin G; Findik D
    Pharmacogn Mag; 2016 Jul; 12(Suppl 4):S471-S474. PubMed ID: 27761077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalization of ZnO Nanoparticles by Glutamic Acid and Conjugation with Thiosemicarbazide Alters Expression of Efflux Pump Genes in Multiple Drug-Resistant
    Nejabatdoust A; Zamani H; Salehzadeh A
    Microb Drug Resist; 2019 Sep; 25(7):966-974. PubMed ID: 30855211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate
    Sangboonruang S; Semakul N; Obeid MA; Ruano M; Kitidee K; Anukool U; Pringproa K; Chantawannakul P; Ferro VA; Tragoolpua Y; Tragoolpua K
    Int J Nanomedicine; 2021; 16():7639-7661. PubMed ID: 34819727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
    Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
    Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria.
    Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S
    Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An
    Niska K; Knap N; Kędzia A; Jaskiewicz M; Kamysz W; Inkielewicz-Stepniak I
    Int J Med Sci; 2016; 13(10):772-782. PubMed ID: 27766027
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination of Rhamnolipid and Chitosan in Nanoparticles Boosts Their Antimicrobial Efficacy.
    Marangon CA; Martins VCA; Ling MH; Melo CC; Plepis AMG; Meyer RL; Nitschke M
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5488-5499. PubMed ID: 31927982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.
    Olsufyeva EN; Shchekotikhin AE; Bychkova EN; Pereverzeva ER; Treshalin ID; Mirchink EP; Isakova EB; Chernobrovkin MG; Kozlov RS; Dekhnich AV; Preobrazhenskaya MN
    Drug Des Devel Ther; 2018; 12():2875-2885. PubMed ID: 30237697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
    J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hybrid of mPEG-b-PCL and G1-PEA dendrimer for enhancing delivery of antibiotics.
    Omolo CA; Kalhapure RS; Agrawal N; Jadhav M; Rambharose S; Mocktar C; Govender T
    J Control Release; 2018 Nov; 290():112-128. PubMed ID: 30312719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.